Article Data

  • Views 337
  • Dowloads 137

Original Research

Open Access

Interaction effects between depression and gender on risk of cancer

  • Eujene Jung1
  • Soon Mi Jang2
  • Hyun Lee Kim3
  • Hyun Ho Ryu4,*,

1Department of emergency medicine, Chonnam National University Hospital, 61456 Gwangju, Republic of Korea

2Department of nephrology and dialysis room, Chonnam National University Hospital, 61456 Gwangju, Republic of Korea

3Department of internal medicine, Chosun University Hospital, 61186 Gwangju, Republic of Korea

4Department of Medicine, Chonnam National University, 61456 Gwangju, Republic of Korea

DOI: 10.22514/jomh.2024.073 Vol.20,Issue 5,May 2024 pp.76-82

Submitted: 23 October 2023 Accepted: 15 November 2023

Published: 30 May 2024

*Corresponding Author(s): Hyun Ho Ryu E-mail: em.ryu.hyunho@cnuh.com

Abstract

Despite the recognized association between depression and cancer risk, there remains a paucity of research exploring the gender-specific variations in this relationship. Our study using prospective cohort data, aimed to investigate the relationship between depression and cancer risk, and to discern how this association varies by gender. Utilizing the Korea Genome and Epidemiology Study (KoGES) prospective cohort data, our primary exposure variables were depression and sex. The occurrence of cancer served as the main outcome of interest. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox regression analysis. To assess the interaction effects of depression and sex on cancer incidence, an interaction analysis was conducted. In cox proportional logistic regression analysis, depression was not associated with cancer risk (HR: 1.14, 95% CI, 0.85–1.51). However, for interaction analysis, in the male group, depression was not identified as a risk factor for cancer, with a HR of 0.88 (95% CI, 0.52–1.48). Conversely, in the female group, depression was associated with a heightened risk of cancer, demonstrating an HR of 1.35 (95% CI, 1.06–1.90)(p for interaction < 0.10). In our study, while depression emerged as a risk factor for cancer in females, it paradoxically appeared to have a protective effect against cancer in males. This underscores the importance of adopting sex-specific strategies in treating depression, potentially aiding in tailoring cancer risk reduction approaches, particularly for males.


Keywords

Depression; Gender; Cancer


Cite and Share

Eujene Jung,Soon Mi Jang,Hyun Lee Kim,Hyun Ho Ryu. Interaction effects between depression and gender on risk of cancer. Journal of Men's Health. 2024. 20(5);76-82.

References

[1] Oh J-K, Weiderpass E. Infection and cancer: global distribution and burden of diseases. Annals of Global Health. 2014; 80: 384–392.

[2] World Health Organization. WHO report on cancer: setting priorities, investing wisely and providing care for all. 2020. Available at: https://www.who.int/publications/i/item/9789240001299/ (Accessed: 08 November 2023).

[3] Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the united states: estimates, projections, and future research. Cancer Epidemiology, Biomarkers & Prevention. 2011; 20: 2006–2014.

[4] Luengo-Fernandez R, Leal J, Gray A, Sullivan R. Economic burden of cancer across the European Union: a population-based cost analysis. The Lancet Oncology. 2013; 14: 1165–1174.

[5] Stein CJ, Colditz GA. Modifiable risk factors for cancer. British Journal of Cancer. 2004; 90: 299–303.

[6] Wu S, Zhu W, Thompson P, Hannun YA. Evaluating intrinsic and non-intrinsic cancer risk factors. Nature Communications. 2018; 9: 3490.

[7] Katzke VA, Kaaks R, Kühn T. Lifestyle and cancer risk. The Cancer Journal. 2015; 21: 104–110.

[8] Anand P, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharmaceutical Research. 2008; 25: 2097–2116.

[9] Spiegel D. Cancer and depression. British Journal of Psychiatry. 1996; 168: 109–116.

[10] Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biological Psychiatry. 2003; 54: 269–282.

[11] Sartorius N. The economic and social burden of depression. Journal of Clinical Psychiatry. 2001; 62: 8–11.

[12] Cassano P, Fava M. Depression and public health: an overview. Journal of Psychosomatic Research. 2002; 53: 849–857.

[13] Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychological Medicine. 2010; 40: 1797–1810.

[14] Sotelo JL, Musselman D, Nemeroff C. The biology of depression in cancer and the relationship between depression and cancer progression. International Review of Psychiatry. 2014; 26: 16–30.

[15] Tsaras K, Papathanasiou IV, Mitsi D, Veneti A, Kelesi M, Zyga S, et al. Assessment of depression and anxiety in breast cancer patients: prevalence and associated factors. Asian Pacific Journal of Cancer Prevention. 2018; 19: 1661–1669.

[16] Hinz A, Herzberg PY, Lordick F, Weis J, Faller H, Brähler E, et al. Age and gender differences in anxiety and depression in cancer patients compared with the general population. European Journal of Cancer Care. 2019; 28: e13129.

[17] DeFlorio ML, Massie MJ. Review of depression in cancer: gender differences. Depression. 1995; 3: 66–80.

[18] Kim SE, Paik HY, Yoon H, Lee JE, Kim N, Sung MK. Sex- and gender-specific disparities in colorectal cancer risk. World Journal of Gastroenterology. 2015; 21: 5167.

[19] Veerman JL, Dowrick C, Ayuso-Mateos JL, Dunn G, Barendregt JJ. Population prevalence of depression and mean beck depression inventory score. British Journal of Psychiatry. 2009; 195: 516–519.

[20] Jia Y, Li F, Liu YF, Zhao JP, Leng MM, Chen L. Depression and cancer risk: a systematic review and meta-analysis. Public Health. 2017; 149: 138–148.

[21] Oerlemans ME, van den Akker M, Schuurman AG, Kellen E, Buntinx F. A meta-analysis on depression and subsequent cancer risk. Clinical Practice and Epidemiology in Mental Health. 2007; 3: 29.

[22] Young K, Singh G. Biological mechanisms of cancer-induced depression. Frontiers in Psychiatry. 2018; 9: 299.

[23] Currier MB, Nemeroff CB. Depression as a risk factor for cancer: from pathophysiological advances to treatment implications. Annual Review of Medicine. 2014; 65: 203–221.

[24] Archer G, Pikhart H, Head J. Do depressive symptoms predict cancer incidence?: 17-year follow-up of the Whitehall II study Journal of Psychosomatic Research. 2015; 79: 595–603.

[25] Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Flint J. Cancer in people with depression or anxiety: record-linkage study. Social Psychiatry and Psychiatric Epidemiology. 2007; 42: 683–689.

[26] Lemogne C, Consoli SM, Melchior M, Nabi H, Coeuret-Pellicer M, Limosin F, et al. Depression and the risk of cancer: a 15-year follow-up study of the GAZEL cohort. American Journal of Epidemiology. 2013; 178: 1712–1720.

[27] Chang HY, Keyes KM, Mok Y, Jung KJ, Shin Y, Jee SH. Depression as a risk factor for overall and hormone-related cancer: the Korean cancer prevention study. Journal of Affective Disorders. 2015; 173: 1–8.

[28] Goldstein BI, Carnethon MR, Matthews KA, McIntyre RS, Miller GE, Raghuveer G, et al. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease. Circulation. 2015; 132: 965–986.

[29] Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA. 2011; 306: 1241–1249.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.

SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)

Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.

Scopus: CiteScore 0.9 (2023) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (https://kanalregister.hkdir.no/publiseringskanaler/Forside).

Submission Turnaround Time

Conferences

Top